Z

yprexa Diabetes

Zyprexa diabetes risks pose a serious and deadly threat to all Zyprexa users. Case studies and clinical trials in the United States and abroad have found that taking Zyprexa significantly increases a patient's risk of developing diabetes and other serious complications. Zyprexa users with a family history of diabetes are at an even greater risk of developing Zyprexa diabetes.

Zyprexa diabetes risks were first acknowledged publicly by the Japanese and British governments in 2002. A political pundit named Bob Whitaker first reported about Zyprexa diabetes risks in his book Mad in America soon after the FDA approved Zyprexa to treat patients with schizophrenia and bipolar disorder in 1996. This Zyprexa diabetes report was developed based on data available to the FDA prior to Zyprexa approval which was not released as public information. The FDA allegedly received reports that two thirds of Zyprexa clinical trial patients were unable to successfully complete pre-marketing trials because of serious side effects including Zyprexa diabetes.

In 2002 Duke University released information about nearly three hundred cases of Zyprexa diabetes in patients taking this atypical prescription drug. Over seventy percent of these cases of Zyprexa diabetes emerged within six months of commencing Zyprexa treatment and were associated with moderate weight gain. Of these Zyprexa diabetes victims, one hundred also developed ketoacidosis, a serious and deadly complication of diabetes. Twenty two Zyprexa diabetes cases also involved the development of pancreatitis, a condition that causes severe inflammation of the pancreas. Zyprexa diabetes claimed the lives of twenty three people in this study alone.

Over one year later, the United States government finally ordered the inclusion of Zyprexa diabetes warnings on all Zyprexa product information. This warning states that people who take Zyprexa are at a significant risk of developing Zyprexa diabetes or related complications as a result. The Zyprexa diabetes warning also includes information about the risks of hyperglycemia, ketoacidosis, coma, and death related to Zyprexa diabetes.

Despite serious Zyprexa diabetes risks, neither the federal government nor Eli Lilly (Zyprexa's maker) has taken any significant steps to protect patients from these life-threatening Zyprexa diabetes risks. The Zyprexa diabetes warning suggests that patients be monitored for deadly side effects, but this is an incredibly feeble attempt to protect consumers and does nothing to prevent patients from developing serious Zyprexa diabetes side effects.

If you or a loved one have taken Zyprexa and developed Zyprexa diabetes or related complications, you may wish to explore your legal rights and options. A person who has developed Zyprexa diabetes has the legal right to seek restitution for their losses through a Zyprexa lawsuit against the makers of this defective drug.

To learn more about Zyprexa diabetes, please contact us to speak with a qualified attorney who can evaluate your case to determine how best to protect and maximize your legal interests.